SDC1 and plasma cell myeloma: Crucially, when Ad[CE1A] efficacy in primary myeloma cells was investigated, myeloma and PCL CD138+ cells showed significant cell death vs. vehicle control (Fig. 2d.i, Supplementary Fig. 4a.i).